Polymyositis: Difference between revisions

No edit summary
Line 18: Line 18:
* Inclusion body myositis
* Inclusion body myositis
* Drug Induced myopathies (EtOH, antimalarials, colchicine, antifungals)
* Drug Induced myopathies (EtOH, antimalarials, colchicine, antifungals)
{{Weakness DDX}}


==Diagnosis==
==Diagnosis==

Revision as of 12:30, 7 February 2016

Background

Idiopathic inflammatory myopathy causing symmetric proximal muscle weakness, elevated CK,and characteristic EMG findings

Clinical Features

  • Symmetrical proximal muscle weakness with insidious onset
  • Generally painless (though 30% have myalgia)
  • Difficulty with kneeling, climbing stairs, combing hair, or rising from a seated position
  • Weak neck extensors causing difficulty of holding head up
  • Associated arthralgias

Differential Diagnosis

  • Hypokalemia
  • Hypophosphatemia
  • ALS
  • Thyroid disorder (hypothyroidism or hyperthyroidism)
  • Myastenia Gravis
  • Myopathies
  • Inclusion body myositis
  • Drug Induced myopathies (EtOH, antimalarials, colchicine, antifungals)

Weakness

Diagnosis

  • CBC, ESR, CRP, CK, UA, RF, ANA, Anti-Jo-1

Management

  • Prednisone 1mg/kg/day for 4-8 weeks until CK returns to reference range
  • Followed by prednisone taper
  • Methotrexate as second line for poor response to corticosteroids
  • Other agents with less evidence: IVIG, TNF Inhibitors

Disposition

  • Rheumatology or neurology consultation either in ED or as outpatient depending on severity of symptoms

References

Tintinalli